+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
Alpha Mannosidosis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Alpha Mannosidosis Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Liver Diseases Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Diseases Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Metabolic Disorders Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Metabolic Disorders Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Research Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Research Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Human Reproductive Technologies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Human Reproductive Technologies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Coagulation Factor Concentrates Market - Global Forecast 2026-2032 - Product Thumbnail Image

Coagulation Factor Concentrates Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more